Post-antifungal effect of polyene, azole and DNA-analogue agents against oral Candida albicans and Candida tropicalis isolates in HIV disease

Journal of Oral Pathology and Medicine

Volumn 30, Issue 8, 2001, Pages 481-488

  Anil, S ^a,b   Ellepola, A N B ^a,c   Samaranayake, L P ^a,d  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF KERALA   (India)

^c UNIVERSITY OF PERADENIYA   (Sri Lanka)

^d Faculty of Dentistry   (Hong Kong)

Author keywords

Antifungal agents; Candidiasis; HIV infection; Postantifungal effect (PAFE)

Indexed keywords

EID: 0034863352     PISSN: 09042512     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0714.2001.030008481.x     Document Type: Article

References (36)

1. Oral mycoses in HIV infection
2. Oral lesions of HIV and AIDS in Asia: An overview
3. Non-albicans oral candidosis in HIV-positive patients
4. Oral carriage of Candida in healthy and HIV-seropositive persons
5. Diagnosis and treatment of oropharyngeal candidiasis in patients infected with HIV: A critical reassessment
6. Oral candidal infections and antimycotics
7. Turbidometric characterization of the postantifungal effect: Comparative studies with amphotericin B, 5-fluomcytosine and miconazole on Candida albicans
8. Standardization of a fluconazole bioassay and correlation of results with those obtained by high-pressure liquid chromatography
9. The postantifungal effect of 5-fluorocytosine on Candida albicans
10. Decreased bactericidal activity during the period of the postantibiotic effect
11. The postantibiotic effect
12. Interrelationship between pharmacokinetics and pharmacodynamics in determining dosage regimens for broad-spectrum cephalosporins
13. The postantifungal effect (PAFE) of antimycotics on oral C albicans isolates and its impact on candidal adhesion
14. The in vitro post-antifungal effect of nystatin on Candida species of oral origin
15. The postantibiotic effect of antifungal agents against common pathogenic yeasts
16. A comparison of oral rinse and imprint sampling techniques for the detection of yeast, coliform and Staphylococcus aureus carriage in the oral cavity
17. Evaluation of the modified API 20C system for identification of clinically important yeasts
18. Multi-centre evaluation of the E-test method for antifungal drug susceptibility testing of Candida spp. and Cryptococcus neoformans
19. Persistent effect of antibiotics on Staphylococcus aureus after exposure for limited periods of time
20. Killing and regrowth of bacteria in vitro: A review
21. Activity of fluconazole: Postantifungal effect, effects of low concentrations and of pretreatment on the susceptibility of Candida albicans to leucocytes
22. Detection and significance of fluconazole resistance in oropharyngeal candidiasis in human immunodeficiency virus-infected patients
23. Candida dubliniensis: Phylogeny and putative virulence factors
24. Identification and expression of multidrug transporters responsible for fluconazole resistance in Candida dubliniensis
25. A comparative study of the efficacy of fluconazole and amphotericin B in the treatment of oropharyngeal candidosis in patients undergoing radiotherapy for head and neck tumours
26. Antifungal pharmacodynamic characteristics of fluconazole and amphotericin B tested against Candida albicans
27. Antifungal susceptibility testing
28. The post-antibiotic effect
29. The influence of antifungal antibiotics on some determinants of virulence in Candida albicans and Cryptococcus neoformans cells
30. Postantifungal effects of echinocandin, azole, and polyene antifungal agents against Candida albicans and Cryptococcus neoformans
31. Antifungal agents
32. Primary site of action of ketoconazole on Candida albicans
33. Mode of action of 5-fluorocytosine
34. Antifungal susceptibility testing of isolates from a randomized, multicenter trial of fluconazole versus amphotericin B as treatment of nonneutropenic patients with candidemia